Naveen Yalamanchi, Director at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 637 shares at $22.00 ($14K) on 2018-08-01, disclosed to the SEC on 2018-08-03.
Scheduled sale ($14k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |